AAP
ROIV icon

Arax Advisory Partners’s Roivant Sciences ROIV Stock Holding History

Arax Advisory Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
6,989
+4,552
+187% +$135K ﹤0.01% 2101
2026
Q1 		$67.5K Buy
2,437
+2,199
+924% +$56.5K ﹤0.01% 1556
2025
Q4 		$5.17K Sell
238
-455
-66% -$8.98K ﹤0.01% 2831
2025
Q3 		$10.5K Buy
+693
New +$8.58K ﹤0.01% 2574
2025
Q1 		– Sell
-88
Closed -$1.04K – 2986
2024
Q4 		$1.04K Hold
88
– – ﹤0.01% 2170
2024
Q3 		$1.02K Buy
+88
New +$1K ﹤0.01% 2252

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Arax Advisory Partners's ROIV Position: Q2 2026 in Review

Arax Advisory Partners increased its Roivant Sciences (ROIV) stake by 187% in Q2 2026, buying an estimated $135K and bringing the position to 6,989 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

Arax Advisory Partners first reported a position in ROIV in Q3 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Arax Advisory Partners held 6,989 shares of Roivant Sciences worth $247K as of Q2 2026.
  • Arax Advisory Partners bought 4,552 Roivant Sciences shares in Q2 2026, an estimated $135K.
  • Roivant Sciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2101 holding.
  • Arax Advisory Partners first reported a position in Roivant Sciences in Q3 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.